The sales of diuretic medicines in Germany are forecasted to show a steady increase from 2024 to 2028, with values gradually rising from 10.3 to 10.8 US Dollars PPP per capita. This indicates a consistent market growth, reflecting a stable demand for diuretic medications. Prior to this forecast, the market stood at 10.2 US Dollars PPP per capita in 2023.
The year-on-year growth is modest, with slight percentage increases each year, signifying a mature market. The forecasted CAGR over this period suggests a small yet steady expansion of the market.
Looking ahead, potential trends to monitor include the aging population in Germany, which could elevate demand for diuretic medicines. Additionally, advancements in pharmaceuticals and healthcare policies might influence market dynamics, as well as the adoption of healthier lifestyles that may alter diuretic usage patterns.
